{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:27:16Z","timestamp":1781792836438,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671745"],"award-info":[{"award-number":["81671745"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21431001"],"award-info":[{"award-number":["21431001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81760626"],"award-info":[{"award-number":["81760626"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.bmc.2018.02.021","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T12:53:01Z","timestamp":1518785581000},"page":"1759-1775","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Discovery of 18\u03b2-glycyrrhetinic acid conjugated aminobenzothiazole derivatives as Hsp90-Cdc37 interaction disruptors that inhibit cell migration and reverse drug resistance"],"prefix":"10.1016","volume":"26","author":[{"given":"Le","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2018.02.021_b0005","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.887927","article-title":"Metastasis results from preexisting variant cells within a malignant tumor","volume":"197","author":"Fidler","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bmc.2018.02.021_b0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szak\u00e1cs","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2018.02.021_b0015","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.bmc.2016.12.034","article-title":"Quercetin-glutamic acid conjugate with a non-hydrolysable linker; a novel scaffold for multidrug resistance reversal agents through inhibition of P-glycoprotein","volume":"25","author":"Kim","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2018.02.021_b0020","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.1021\/acs.jmedchem.6b00912","article-title":"Novel Tetrahydropyrido[4,3-d]pyrimidines as Potent Inhibitors of Chaperone Heat Shock Protein 90","volume":"59","author":"Jiang","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.02.021_b0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejmech.2016.11.024","article-title":"Terminal functionalized thiourea-containing dipeptides as multidrug-resistance reversers that target 20S proteasome and cell proliferation","volume":"126","author":"Qin","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2018.02.021_b0030","first-page":"84","article-title":"An autophagy inhibitor enhances the inhibition of cell proliferation","volume":"5","author":"Yao","year":"2012","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.bmc.2018.02.021_b0035","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejphar.2013.09.044","article-title":"Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistance","volume":"721","author":"Gong","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmc.2018.02.021_b0040","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc1716","article-title":"Hsp90 and the chaperoning of cancer","volume":"5","author":"Whitesell","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2018.02.021_b0045","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1016\/j.bmcl.2017.10.036","article-title":"Repurposing Hsp90 inhibitors as antibiotics targeting histidine kinases","volume":"27","author":"Vo","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2018.02.021_b0050","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1021\/jm500823a","article-title":"Progress in the discovery and development of heat shock protein 90 (Hsp90) inhibitors","volume":"57","author":"Bhat","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.02.021_b0055","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1021\/jm401536b","article-title":"Synthesis and evaluation of new Hsp90 inhibitors based on a 1,4,5-trisubstituted 1,2,3-triazole scaffold","volume":"57","author":"Taddei","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.02.021_b0060","doi-asserted-by":"crossref","first-page":"9053","DOI":"10.1021\/acs.jmedchem.7b01395","article-title":"Design, synthesis, and biological activities of vibsanin B derivatives: a new class of HSP90 C-terminal inhibitors","volume":"60","author":"Shao","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.02.021_b0065","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1476-4598-13-150","article-title":"FW-04\u2212806 inhibits proliferation and induces apoptosis in human breast cancer cells by binding to N-terminus of Hsp90 and disrupting Hsp90-Cdc37 complex formation","volume":"13","author":"Huang","year":"2014","journal-title":"Mol Cancer"},{"key":"10.1016\/j.bmc.2018.02.021_b0070","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1021\/acs.jmedchem.5b01106","article-title":"Development of heat shock protein (Hsp90) inhibitors to combat resistance to tyrosine kinase inhibitors through Hsp90\u2212kinase interactions","volume":"59","author":"Wang","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.02.021_b0075","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.chembiol.2015.08.018","article-title":"Natural product kongensin a is a non-canonical Hsp90 inhibitor that blocks RIP3-dependent necroptosis","volume":"23","author":"Li","year":"2016","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.bmc.2018.02.021_b0080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejmech.2017.04.074","article-title":"Structure-based virtual screening and optimization of modulators targeting Hsp90-Cdc37 interaction","volume":"136","author":"Wang","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2018.02.021_b0085","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.molcel.2008.07.021","article-title":"Hsp90-dependent activation of protein kinases is regulated by chaperone-targeted dephosphorylation of Cdc37","volume":"31","author":"Vaughan","year":"2008","journal-title":"Mol Cell"},{"key":"10.1016\/j.bmc.2018.02.021_b0090","first-page":"4614","article-title":"Cdc37 enhances proliferation and is necessary for normal human prostate epithelial cell survival","volume":"63","author":"Schwarze","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmc.2018.02.021_b0095","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4161\/cc.8.3.7531","article-title":"Targeting CDC37: An alternative, kinase-directed strategy for disruption of oncogenic chaperoning","volume":"8","author":"Smith","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bmc.2018.02.021_b0100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1158\/1535-7163.MCT-07-0484","article-title":"A novel Hsp90 inhibitor to disrupt Hsp90\/Cdc37 complex against pancreatic cancer cells","volume":"7","author":"Zhang","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmc.2018.02.021_b0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jff.2015.06.052","article-title":"Natural plant flavonoid apigenin directly disrupts Hsp90\/Cdc37 complex and inhibits pancreatic cancer cell growth and migration","volume":"18","author":"He","year":"2015","journal-title":"J Functional oods"},{"key":"10.1016\/j.bmc.2018.02.021_b0110","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1021\/jm8007486","article-title":"Gedunin, a Novel Hsp90 Inhibitor: Semisynthesis of Derivatives and Preliminary Structure\u2212Activity Relationships","volume":"51","author":"Brandt","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.02.021_b0115","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejmech.2016.02.020","article-title":"Design, synthesis, and structure-activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2","volume":"112","author":"Zou","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2018.02.021_b0120","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1016\/j.bmcl.2014.06.054","article-title":"Synthesis and evaluation of triazole linked glycosylated 18\u03b2-glycyrrhetinic acid derivatives as anticancer agents","volume":"24","author":"Parida","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2018.02.021_b0125","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1016\/j.bmc.2017.08.002","article-title":"Conjugates of 18b-glycyrrhetinic acid derivatives with 3-(1H-benzo[d] imidazol-2-yl)propanoic acid as Pin1 inhibitors displaying anti-prostate cancer ability","volume":"25","author":"Li","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2018.02.021_b0130","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1016\/j.bmc.2007.05.057","article-title":"The synthesis of 18\u03b2-glycyrrhetinic acid derivatives which have increased antiproliferative and apoptotic effects in leukemia cells","volume":"15","author":"Liu","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2018.02.021_b0135","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ejmech.2012.05.028","article-title":"Benzothiazoles: search for anticancer agents","volume":"54","author":"Noolvi","year":"2012","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2018.02.021_b0140","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/157019312799079929","article-title":"Chemistry and Biological Activities of 1,3-Benzothiazoles","volume":"9","author":"Vasconcelos","year":"2012","journal-title":"Mini Rev Org Chem"},{"key":"10.1016\/j.bmc.2018.02.021_b0145","first-page":"977","article-title":"Synthesis and biological evaluation of cis-restricted triazole\/tetrazole mimics of combretastatin-benzothiazole hybrids as tubulin polymerization inhibitors and apoptosis inducers","volume":"25","author":"Rao","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2018.02.021_b0150","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejmech.2012.08.021","article-title":"Synthesis and biological evaluation of combretastatin-amidobenzothiazole conjugates as potential anticancer agents","volume":"56","author":"Kamal","year":"2012","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2018.02.021_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2017.04.004","article-title":"Optimization and biological evaluation of 2-aminobenzothiazole derivatives as Aurora B kinase inhibitors","volume":"25","author":"Lee","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2018.02.021_b0160","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13065-016-0222-8","article-title":"Design, synthesis, and biological evaluation of the novel glycyrrhetinic acid-cinnamoyl hybrids as anti-tumor agents","volume":"10","author":"Guo","year":"2016","journal-title":"Chem Cent J"},{"key":"10.1016\/j.bmc.2018.02.021_b0165","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0003-2697(02)00229-4","article-title":"Homogeneous time-resolved fluorescence assay for identifying p53 interactions with its protein partners, directly in a cellular extract","volume":"308","author":"Leblanc","year":"2002","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bmc.2018.02.021_b0170","doi-asserted-by":"crossref","first-page":"e3055","DOI":"10.1038\/cddis.2017.441","article-title":"Blocking autophagy enhances the apoptotic effect of 18\u03b2-glycyrrhetinic acid on human sarcoma cells via endoplasmic reticulum stress and JNK activation","volume":"8","author":"Shen","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bmc.2018.02.021_b0175","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/092986707779313372","article-title":"Possible effects of early treatments of hsp90 inhibitors on preventing the evolution of drug resistance to other anti-cancer drugs","volume":"14","author":"Xiao","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2018.02.021_b0180","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ejmech.2017.07.020","article-title":"Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation","volume":"138","author":"Huang","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2018.02.021_b0185","doi-asserted-by":"crossref","first-page":"45298","DOI":"10.18632\/oncotarget.16847","article-title":"Migration pattern, actin cytoskeleton organization and response to PI3K-, mTOR-, and Hsp90-inhibition of glioblastoma cells with different invasive capacities","volume":"8","author":"Memmel","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmc.2018.02.021_b0190","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1023\/A:1009616228304","article-title":"Role of reactive oxygen species (ROS) in apoptosis induction","volume":"5","author":"Simon","year":"2000","journal-title":"Apoptosis"},{"key":"10.1016\/j.bmc.2018.02.021_b0195","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejmech.2015.03.058","article-title":"Synthesis and pharmacological evaluation of novel bisindole derivatives bearing oximes moiety: Identification of novel proapoptotic agents","volume":"95","author":"Qu","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2018.02.021_b0200","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0304-4165(99)00073-2","article-title":"Bcl-2 protects against FCCP-induced apoptosis and mitochondrial membrane potential depolarization in PC12 cells","volume":"1428","author":"Dispersyn","year":"1999","journal-title":"Biochimica Et Biophysica Acta-General Subjects"},{"key":"10.1016\/j.bmc.2018.02.021_b0205","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/01.RES.85.10.940","article-title":"Regulation of Bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes","volume":"85","author":"Cook","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.bmc.2018.02.021_b0210","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1126\/science.275.5303.1132","article-title":"The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis","volume":"275","author":"Kluck","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bmc.2018.02.021_b0215","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tiv.2016.05.008","article-title":"Cytotoxicity of carteolol to human corneal epithelial cells by inducing apoptosis via triggering the Bcl-2 family protein-mediated mitochondrial pro-apoptotic pathway","volume":"35","author":"Shan","year":"2016","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.bmc.2018.02.021_b0220","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bmc.2017.12.001","article-title":"Design, synthesis and pharmacological evaluation of new acyl sulfonamides as potent and selective Bcl-2 inhibitors","volume":"26","author":"Liu","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2018.02.021_b0225","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0092-8674(03)01027-4","article-title":"The mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(Cdc37)","volume":"116","author":"Roe","year":"2004","journal-title":"Cell"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089617324264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089617324264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:55:21Z","timestamp":1760835321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089617324264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0968089617324264"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2018.02.021","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 18\u03b2-glycyrrhetinic acid conjugated aminobenzothiazole derivatives as Hsp90-Cdc37 interaction disruptors that inhibit cell migration and reverse drug resistance","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2018.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}